PDUFA VIII: US FDA Willing To Risk One-Time Potential Revenue Reduction In Five-Year Cycle

 
• By Derrick Gingery
  
The FDA could see a one-time PDUFA revenue reduction under a proposal for the upcoming program cycle. (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Rx-to-OTC Switch

More from Health